Latest Regenerative medicine Stories
SAN DIEGO, NEW YORK, and LOS ANGELES, Jan.
Proprietary Products Revenue Growth of 25% over 2013; HypoThermosol® and CryoStor® Now Embedded in 175 Regenerative Medicine Clinical Trials BOTHELL, Wash., Jan.
This week an accepted-ahead-of-print report published online in the journal Stem Cell Research describes the development of a new technology from the stem cell technology start-up Asymmetrex that
SAN DIEGO, Jan.
The 2015 Regenerative Medicine & Advanced Therapies State of the Industry Briefing will take place Monday, January 12, 2015 in San Francisco WASHINGTON,
Meetings focused on investors, analysts, and potential partners for RCS-01 and RCT-01 cell therapies VANCOUVER, Jan. 7, 2015 /CNW/ - RepliCel Life Sciences Inc.
Cryo-Cell International, Inc.
Upcoming Adult Stem Cell Lectures: Seal Beach – Sunday, January 11 and Friday, January 16; Laguna Hills – Tuesday, January 13; and Lake Forest – Saturday, January 17. Seal
Proprietary, Clinical Grade HypoThermosol® and CryoStor® Extending Shelf Life and Improving Survival & Function of CAR-T Cells, Dendritic Cells, Etc. BOTHELL, Wash., Jan.
- totally perplexed and mixed up.
More Images (1 images) »